Clinical Trials Sponsored by Quidel Corporation

Total 6479 results

Quidel Corporation

Completed

QuickVue Influenza A + B Test Field Study (QuickVue Flu)

Influenza A, Influenza B

United States
Quidel Corporation

Completed

Strep A FIA Field Study, Sofia

Group A Streptococcus

United States
Quidel Corporation

Completed

Sofia hCG FIA Field Study

Pregnancy, Early Detection

United States
Quidel Corporation

Completed

Strep A Fluorescent Immunoassay and Analyzer Field Study

Strep Throat

United States
Quidel Corporation

Completed

QuickVue Influenza A+B Clinical Field Trial

Influenza

Australia
Quidel Corporation

Completed

Sofia 2 Lyme FIA Whole Blood Clinical Study

Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)

United States
Quidel Corporation

Completed

"Solana™ Trichomonas Assay Field Study"

Trichomonas Vaginalis

United States
Quidel Corporation

Completed

Sofia RSV FIA Field Study

Respiratory Syncytial Virus

United States
Quidel Corporation

Terminated

Sofia Strep A FIA Field Study

Strep Throat | Group A Streptococcus

United States
Quidel Corporation

Completed

"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"

Influenza

United States
University Hospital, Geneva
Quidel Corporation

Completed

Comparison of Two Rapid Antigen Detection Tests for the Detection of Group-A Streptococcal Pharyngitis in Children

Pharyngitis
University of Wisconsin, Madison
Quidel Corporation

Completed

Nasal Swab Home Collection Kit (NSHC Kit) Study

Influenza Viral Infections

United States
Guided Therapeutics

Enrolling by invitation

The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia

Cervical Dysplasia

United States
Guided Therapeutics

Unknown

Initial Study With the CNDS Advanced Cervical Scan to Recalibrate Spectral Data for Use in Future Screening Studies (Spectral)

Cervical Disease

United States
Liverpool University Hospitals NHS Foundation Trust
Abbott Diagnostics Division; Quidel Corporation; Siemens Corporation, Corporate... and other collaborators

Recruiting

Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway (MACROS2)

Chest Pain | Acute Coronary Syndrome | Troponin | Point-of-care Systems

United Kingdom
Radboud University Medical Center
Terumo Medical Corporation; Quirem Medical B.V.

Recruiting

Percutaneous Holmium Injection in Pancreatic Cancer (SLOTH-2a)

Pancreas Cancer

Netherlands
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Pharma Guide CRO

Completed

Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)

Healthy

Egypt
Guided Therapy Systems
More Foundation

Completed

ITU Treatment for Chronic Epicondylitis Musculoskeletal Pain Reduction (ITU)

Tennis Elbow

United States
Guided Therapy Systems
University of Arizona

Completed

Intense Therapeutic Ultrasound - Treatment for Chronic Plantar Fascia Musculoskeletal Pain Reduction (ITU)

Chronic Plantar Fasciitis

United States
Guided Therapeutics
National Cancer Institute (NCI)

Completed

Spectroscopic Evaluation of Cervical Neoplasia

Cervical Neoplasia

United States
Jose Luis Quiles Morales

Recruiting

Adjuvant Treatment in Elderly Patients With Periodontitis Through the Administration of a Supplement Rich in Oleuropein From the Olive Leaf (OLIVAGING)

Periodontitis

Spain
Radboud University Medical Center
Quirem Medical B.V.

Completed

Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer (SLOTH-1)

Pancreas Cancer

Netherlands
Radboud University Medical Center
Quirem Medical B.V.

Completed

Real-time Imaging of Holmium Radioembolization: a Feasibility Study (Emeritus)

Liver Metastases | Liver Cancer

Netherlands
Maastricht University Medical Center
Nederlandse Zuivel Organisatie

Completed

Postprandial Effects of Milk and Milk Constituents

Inflammation | Hyperlipidemia

Netherlands
Maastricht University Medical Center
Nederlandse Zuivel Organisatie

Completed

Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning

Insulin | Glucose Metabolism

Netherlands
Maastricht University Medical Center
Nederlandse Zuivel Organisatie

Completed

Effect of Different Protein Diets on Glucose and Insulin Metabolism and Substrate Partitioning

Insulin | Glucose Metabolism
Maastricht University Medical Center
Nederlandse Zuivel Organisatie

Completed

Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning in Impaired Glucose Tolerant (IGT) Men

Glucose Intolerance

Netherlands
Clear Guide Medical
University of Maryland

Withdrawn

Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/MR) (MANIFOLD I)

Renal Biopsy or Ablation
Clear Guide Medical
Johns Hopkins University

Unknown

Ultrasound-CT Fusion System for Interventional Radiology Procedures

CT Guided Biopsy | CT Guided Drain Placement Within the Abdomen or Pelvis | CT Guided Injection of Muscle or Nerve Within the Pelvis

United States
Clear Guide Medical
Johns Hopkins University

Withdrawn

Modality Augmentation for Navigation: Intuitive Fusion With Optical Lightweight Device (US/CBCT) (MANIFOLD II)

Hepatic Biopsy or Ablation
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System (ACCESS PTS)

Deep Vein Thrombosis | Post-thrombotic Syndrome

United States
Guidant Corporation
Boston Scientific Corporation

Completed

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device (SEPTAL-CRT)

Ventricular Fibrillation | Ventricular Tachycardia | Systolic Heart Failure

France, Spain
Mayo Clinic
Clear Guide Medical Inc.

Enrolling by invitation

A Study of Optical Fusion Trans-Perineal Grid

Prostate Biopsy

United States
Clear Guide Medical
University of Miami

Completed

Training and Evaluation of Ultrasound-Guided Procedures

Learning Anesthesia Procedures

United States

Clinical Trials Sponsored by Quidel Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations